The growth of acute kidney injury: A rising tide or just closer attention to detail?

Kidney International

Volumn 87, Issue 1, 2015, Pages 46-61

  Siew, Edward D ^a   Davenport, Andrew ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Acute renal failure; Epidemiology and outcomes; Nephrotoxicity

Indexed keywords

CREATININE;

ACUTE KIDNEY FAILURE; COMORBIDITY; CREATININE BLOOD LEVEL; DISEASE PREDISPOSITION; DISEASE SEVERITY; HEALTH CARE PERSONNEL; HEMODIALYSIS; HOSPITALIZATION; HUMAN; INCIDENCE; MORBIDITY; MORTALITY; REIMBURSEMENT; REVIEW; UNITED STATES; UREA NITROGEN BLOOD LEVEL; ACUTE KIDNEY INJURY; COMPLICATION; FORECASTING; UTILIZATION;

ACUTE KIDNEY INJURY; FORECASTING; HUMANS; INCIDENCE; RENAL DIALYSIS;

EID: 84920278409     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2014.293     Document Type: Review

References (181)

1. Marketos SG, Eftychiadis AG, Diamandopoulos A. Acute renal failure according to ancient Greek and Byzantine medical writers. J R Soc Med 1993; 86: 290-293.
2. Swan RC, Merrill JP. The clinical course of acute renal failure. Medicine 1953; 32: 215.
3. Smith HJ. The Kidney: Structure and Function in Health and Disease fourth printing. Oxford University Press: London, England, 1964; 810.
4. Uchino S, Kellum JA, Bellomo R et al. Acute renal failure in critically ill patients: a multinational, multicenter study. Jama 2005; 294: 813-818.
5. Mehta RL, Pascual MT, Soroko S et al. Spectrum of acute renal failure in The intensive care unit: The PICARD experience. Kidney Int 2004; 66: 1613-1621.
6. Xue JL, Daniels F, Star RA et al. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 2006; 17: 1135-1142.
7. Waikar SS, Curhan GC, Wald R et al. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol 2006; 17: 1143-1150.
8. Hsu RK, McCulloch CE, Dudley RA et al. Temporal Changes in Incidence of Dialysis-Requiring AKI. J Am Soc Nephrol 2013; 24: 37-42.
9. Hsu CY, McCulloch CE, Fan D et al. Community-based incidence of acute renal failure. Kidney Int 2007; 72: 208-212.
10. Siddiqui NF, Coca SG, Devereaux PJ et al. Secular trends in acute dialysis after elective major surgery-1995 to 2009. CMAJ 2012; 184: 1237-1245.
11. Hsu CY, Vittinghoff E, Lin F et al. The incidence of end-stage renal disease is increasing faster than The prevalence of chronic renal insufficiency. Ann Intern Med 2004; 141: 95-101.
12. Wald R, Quinn RR, Luo J et al. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 2009; 302: 1179-1185.
13. Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int 2008; 73: 538-546.
14. Chertow GM, Burdick E, Honour M et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16: 3365-3370.
15. Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2011; 81: 442-448.
16. Hsu CY. Where is The epidemic in kidney disease? J Am Soc Nephrol 2010; 21: 1607-1611.
17. Siew ED, Himmelfarb J. The inexorable rise of AKI: can we bend The growth curve? J Am Soc Nephrol 2013; 24: 3-5.
18. Chawla LS, Kimmel PL. Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int 2012; 82: 516-524.
19. Lameire N, Van Biesen W, Vanholder R. The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol 2006; 2: 364-377.
20. Hwang YJ, Shariff SZ, Gandhi S et al. Validity of The International Classification of Diseases, Tenth Revision code for acute kidney injury in elderly patients at presentation to The emergency department and at hospital admission. BMJ Open 2012; 2: 1-11.
21. Grams ME, Waikar SS, MacMahon B et al. Performance and limitations of administrative data in The identification of AKI. Clin J Am Soc Nephrol CJASN 2014; 9: 682-689.
22. Hou SH, Bushinsky DA, Wish JB et al. Hospital-acquired renal insufficieny: a prospective study. Am J Med 1983; 74: 243.
23. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930-936.
24. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996; 275: 1489-1494.
25. Bellomo R, Ronco C, Kellum JA et al. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of The Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212.
26. Mehta RL, Kellum JA, Shah SV et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31.
27. Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int Supp 2012; 2: 19.
28. Siew ED, Matheny ME, Ikizler TA et al. Commonly used surrogates for baseline renal function affect The classification and prognosis of acute kidney injury. Kidney Int 2010; 77: 536-542.
29. Bagshaw SM, Uchino S, Cruz D et al. A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury. Nephrol Dial Transplant 2009; 24: 2739-2744.
30. Waikar SS, Wald R, Chertow GM et al. Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol 2006; 17: 1688-1694.
31. Metcalfe W, Simpson M, Khan IH et al. Acute renal failure requiring renal replacement therapy: incidence and outcome. QJM 2002; 95: 579-583.
32. Hsu RK, McCulloch CE, Dudley RA et al. Temporal Changes in Incidence of dialysis-requiring Acute Kidney Injury. Journal of The American Society of Nephrology 2013; 24: 37-42.
33. Rosansky S, Glassock RJ, Clark WF. Early start of dialysis: a critical review. Clin J Am Soc Nephrol 2011; 6: 1222-1228.
34. Rosansky SJ, Eggers P, Jackson K et al. Early start of hemodialysis may be harmful. Arch Intern Med 2011; 171: 396-403.
35. Liu KD, Himmelfarb J, Paganini E et al. Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol 2006; 1: 915-919.
36. Shiao CC, Wu VC, Li WY et al. Late initiation of renal replacement therapy is associated with worse outcomes in acute kidney injury after major abdominal surgery. Crit Care 2009; 13: R171.
37. Thakar CV, Rousseau J, Leonard AC. Timing of dialysis initiation in AKI in ICU: international survey. Crit Care 2012; 16: R237.
38. Clark E, Wald R, Walsh M et al. Timing of initiation of renal replacement therapy for acute kidney injury: a survey of nephrologists and intensivists in Canada. Nephrol Dial Transplant 2012; 27: 2761-2767.
39. Wiedemann HP, Wheeler AP, Bernard GR et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354: 2564-2575.
40. Liu KD, Thompson BT, Ancukiewicz M et al. Acute kidney injury in patients with acute lung injury: impact of fluid accumulation on classification of acute kidney injury and associated outcomes. Crit Care Med 2011; 39: 2665-2671.
41. Grams ME, Estrella MM, Coresh J et al. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 2011; 6: 966-973.
42. Butcher BW, Liu KD. Fluid overload in AKI: epiphenomenon or putative effect on mortality? Curr Opin Crit Care 2012; 18: 593-598.
43. Grams ME, Astor BC, Bash LD et al. Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury. J Am Soc Nephrol 2010; 21: 1757-1764.
44. Hsu CY, Ordonez JD, Chertow GM et al. The risk of acute renal failure in patients with chronic kidney disease. Kidney Int 2008; 74: 101-107.
45. Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decreased kidney function in The adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12.
46. Coresh J, Walser M, Hill S. Survival on dialysis among chronic renal failure patients treated with a supplemented low-protein diet before dialysis. J Am Soc Nephrol 1995; 6: 1379-1385.
47. Siddiqui NF, Coca SG, Devereaux PJ et al. Secular trends in acute dialysis after elective major surgery-1995 to 2009. CMAJ 2012; 184: 1237-1245.
48. Winkelmayer WC, Schneeweiss S, Mogun H et al. Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis 2005; 46: 225-232.
49. Fleet JL, Dixon SN, Shariff SZ et al. Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes. BMC Nephrol 2013; 14: 81.
50. Kern EF, Maney M, Miller DR et al. Failure of ICD-9-CM codes to identify patients with comorbid chronic kidney disease in diabetes. Health Serv Res 2006; 41: 564-580.
51. Owan TE, Hodge DO, Herges RM et al. Secular trends in renal dysfunction and outcomes in hospitalized heart failure patients. J Card Fail 2006; 12: 257-262.
52. Writing Group Members Lloyd-Jones D, Adams RJ et al. Heart disease and stroke statistics-2010 update: a report from The American Heart Association. Circulation 2010; 121: e46-e215.
53. Adams KF Jr, Uddin N, Patterson JH. Clinical predictors of in-hospital mortality in acutely decompensated heart failure-piecing together The outcome puzzle. Congest Heart Fail 2008; 14: 127-134.
54. Grams ME, Astor BC, Bash LD et al. Albuminuria and estimated glomerular filtration rate independently associate with acute kidney injury. J Am Soc Nephrol 2010; 21: 1757-1764.
55. James MT, Hemmelgarn BR, Wiebe N et al. Glomerular filtration rate, proteinuria, and The incidence and consequences of acute kidney injury: a cohort study. Lancet 2010; 376: 2096-2103.
56. Hsu RK, Hsu CY. Proteinuria and reduced glomerular filtration rate as risk factors for acute kidney injury. Curr Opin Nephrol Hypertens 2011; 20: 211-217.
57. Fraze T, Jiang JH, Burgess J. Hospital Stays for Patients with Diabetes, 2008 (Statistical Brief #93). Healthcare Cost and Utilization Project (HCUP). http://www.hcup-us.ahrq.gov/reports/statbriefs/sb93.pdf. 2010.
58. Billings FTt, Pretorius M, Schildcrout JS et al. Obesity and oxidative stress predict AKI after cardiac surgery. J Am Soc Nephrol 2012; 23: 1221-1228.
59. Patil H, Astik G, House JA et al. Prevalence of grade II and III obesity among patients hospitalized with cardiovascular diagnoses in 2002 v. 2009. Mo Med 2012; 109: 397-401.
60. Nagamine M, Jiang J, Merril CT. Trends in elderly Hospitalizations, 1997-2004. Statistical Brief #14. Healthcare Cost and Utilization Project (HCUP). www.hcup-us.ahrq.gov/reports/statbriefs/sb14.pdf 2006.
61. Rubenfeld GD, Caldwell E, Peabody E et al. Incidence and outcomes of acute lung injury. N Eng J Med 2005; 353: 1685-1693.
62. Martin GS, Mannino DM, Moss M. The effect of age on The development and outcome of adult sepsis. Crit Care Med 2006; 34: 15-21.
63. Anderson S, Eldadah B, Halter JB et al. Acute kidney injury in older adults. J Am Soc Nephrol 2011; 22: 28-38.
64. Seymour CW, Rea TD, Kahn JM et al. Severe sepsis in pre-hospital emergency care: analysis of incidence, care, and outcome. Am J Respir Crit Care Med 2012; 186: 1264-1271.
65. Martin GS, Mannino DM, Eaton S et al. The epidemiology of sepsis in The United States from 1979 through 2000. N Engl J Med 2003; 348: 1546-1554.
66. Dombrovskiy VY, Martin AA, Sunderram J et al. Rapid increase in hospitalization and mortality rates for severe sepsis in The United States: a trend analysis from 1993 to 2003. Crit Care Med 2007; 35: 1244-1250.
67. Fry AM, Shay DK, Holman RC et al. Trends in hospitalizations for pneumonia among persons aged 65 years or older in The United States, 1988-2002. JAMA 2005; 294: 2712-2719.
68. Heywood JT, Fonarow GC, Costanzo MR et al. High prevalence of renal dysfunction and its impact on outcome in 118, 465 patients hospitalized with acute decompensated heart failure: a report from The ADHERE database. J Card Fail 2007; 13: 422-430.
69. Fonarow GC, Adams KF Jr, Abraham WT et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005; 293: 572-580.
70. Forman DE, Butler J, Wang Y et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 2004; 43: 61-67.
71. Logeart D, Tabet JY, Hittinger L et al. Transient worsening of renal function during hospitalization for acute heart failure alters outcome. Int J Cardiol 2008; 127: 228-232.
72. Hassan A, Newman A, Ko DT et al. Increasing rates of angioplasty versus bypass surgery in Canada, 1994-2005. Am Heart J 2010; 160: 958-965.
73. Amin AP, Salisbury AC, McCullough PA et al. Trends in The incidence of acute kidney injury in patients hospitalized with acute myocardial infarction. Arch Intern Med 2012; 172: 246-253.
74. Neilson EG, Johnson KB, Rosenbloom ST et al. The impact of peer management on test-ordering behavior. Ann Intern Med 2004; 141: 196-204.
75. Lenihan CR, Montez-Rath ME, Mora Mangano CT et al. Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008. Ann Thorac Surg 2013; 95: 20-28.
76. Serruys PW, Morice MC, Kappetein AP et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-972.
77. Farkouh ME, Domanski M, Sleeper LA et al. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med 2012; 367: 2375-2384.
78. Salahudeen AK, Bonventre JV. Onconephrology: The latest frontier in The war against kidney disease. J Am Soc Nephrol 2013; 24: 26-30.
79. Lam AQ, Humphreys BD. Onco-nephrology: AKI in The cancer patient. Clin J Am Soc Nephrol 2012; 7: 1692-1700.
80. Perazella MA, Berns JS, Rosner MH. Cancer and The kidney: The growth of onco-nephrology. Adv Chronic Kidney Dis 2014; 21: 4-6.
81. Siegel R, Ma J, Zou Z et al. Cancer Statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
82. Salahudeen AK, Doshi SM, Pawar T et al. Incidence rate, clinical correlates, and outcomes of AKI in patients admitted to a comprehensive cancer center. Clin J Am Soc Nephrol 2013; 8: 347-354.
83. Perazella MA. Onco-nephrology: renal toxicities of chemotherapeutic agents. Clin J Am Soc Nephrol 2012; 7: 1713-1721.
84. Uchino S. The epidemiology of acute renal failure in The world. Curr Opin Crit Care 2006; 12: 538-543.
85. Hui-Stickle S, Brewer ED, Goldstein SL. Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 2005; 45: 96-101.
86. Moffett BS, Goldstein SL. Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children. Clin J Am Soc Nephrol 2011; 6: 856-863.
87. Perazella MA. Drug use and nephrotoxicity in The intensive care unit. Kidney Int 2012; 81: 1172-1178.
88. Myburgh JA, Finfer S, Bellomo R et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367: 1901-1911.
89. Perner A, Haase N, Guttormsen AB et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367: 124-134.
90. Zarychanski R, Abou-Setta AM, Turgeon AF et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 2013; 309: 678-688.
91. Yunos NM, Bellomo R, Hegarty C et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012; 308: 1566-1572.
92. Kellum JA, Lameire N. for The KAKIGWG. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 2013; 17: 204.
93. Palevsky PM, Liu KD, Brophy PD et al. KDOQI US commentary on The 2012 KDIGO clinical practice guideline for acute kidney injury. Am J Kidney Dis 2013; 61: 649-672.
94. Rivers E, Nguyen B, Havstad S et al. Early goal-directed therapy in The treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377.
95. Levy MM, Dellinger RP, Townsend SR et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 2010; 36: 222-231.
96. Williams AW, Dwyer AC, Eddy AA et al. Critical and honest conversations: The evidence behind The 'Choosing Wisely' campaign recommendations by The American Society of Nephrology. Clin J Am Soc Nephrol 2012; 7: 1664-1672.
97. Plantinga L, Grubbs V, Sarkar U et al. Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in The United States. Ann Family Med 2011; 9: 423-430.
98. Peralta CA, Shlipak MG, Wassel-Fyr C et al. Association of antihypertensive therapy and diastolic hypotension in chronic kidney disease. Hypertension 2007; 50: 474-480.
99. Abuelo JG. Normotensive ischemic acute renal failure. N Engl J Med 2007; 357: 797-805.
100. Lewis EJ, Hunsicker LG, Bain RP et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993; 329: 1456-1462.
101. Kramer BK, Schweda F. Ramipril in non-diabetic renal failure (REIN study). Ramipril Efficiency in Nephropathy study. Lancet 1997; 350: 736 author reply 736-737.
102. Lewis EJ, Hunsicker LG, Clarke WR et al. Renoprotective effect of The angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860.
103. Yusuf S, Sleight P, Pogue J et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 145-153.
104. Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of The Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289: 2560-2572.
105. KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007; 49: S12-154.
106. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-266.
107. Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100.
108. Jain AK, Cuerden MS, McLeod I et al. Reporting of The estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD. Kidney Int 2012; 81: 1248-1253.
109. Cox ZL, McCoy AB, Matheny ME et al. Adverse drug events during AKI and its recovery. Clin J Am Soc Nephrol 2013; 8: 1070-1078.
110. Arora P, Rajagopalam S, Ranjan R et al. Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery. Clin J Am Soc Nephrol 2008; 3: 1266-1273.
111. Rim MY, Ro H, Kang WC et al. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study. Am J Kidney Dis 2012; 60: 576-582.
112. Mann JF, Schmieder RE, McQueen M et al. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet 2008; 372: 547-553.
113. Fried LF, Emanuele N, Zhang JH et al. Combined Angiotensin inhibition for The treatment of diabetic nephropathy. N Engl J Med 2013; 369: 1892-1903.
114. Lapi F, Azoulay L, Yin H et al. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ 2013; 346: e8525.
115. Okusa M, Davenport A. Reading between The guidelines-The KIDGO Practice Guideline on acute kidney injury in The individual patient. Kidney Int 2013; 85: 39-48.
116. Davenport A, Cholongitas E, Xirouchakis E et al. Pitfalls in assessing renal function in patients with cirrhosis-potential inequity for access to treatment of hepatorenal failure and liver transplantation. Nephrol Dial Transplant 2011; 26: 2735-2742.
117. Macedo E, Bouchard J, Soroko SH et al. Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit Care 2010; 14: R82.
118. Coca SG, Garg AX, Swaminathan M et al. Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery. Nephrol Dial Transplant 2013; 28: 2787-2799.
119. Testani JM, Chen J, McCauley BD et al. Potential effects of aggressive decongestion during The treatment of decompensated heart failure on renal function and survival. Circulation 2010; 122: 265-272.
120. Testani JM, Brisco MA, Chen J et al. Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion. J Am Coll Cardiol 2013; 62: 516-524.
121. Murray PT, Mehta RL, Shaw A et al. Current use of biomarkers in acute kidney injury: report and summary of recommendations from The 10th Acute Dialysis Quality Initiative consensus conference. Kidney Int 2014; 85: 513-521.
122. McCullough PA, Bouchard J, Waikar SS et al. Implementation of novel biomarkers in The diagnosis, prognosis, and management of acute kidney injury: executive summary from The Tenth Consensus Conference of The Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol 2013; 182: 5-12.
123. McCullough PA, Shaw AD, Haase M et al. Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from The tenth acute dialysis quality initiative consensus conference. Contrib Nephrol 2013; 182: 13-29.
124. Coca SG, Garg AX, Thiessen-Philbrook H et al. Urinary biomarkers of AKI and mortality 3 years after cardiac surgery. J Am Soc Nephrol 2014; 25: 1063-1071.
125. Haase M, Devarajan P, Haase-Fielitz A et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol 2011; 57: 1752-1761.
126. Belcher JM, Sanyal AJ, Peixoto AJ et al. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology 2014; 60: 622-632.
127. Hsu RK, McCulloch CE, Ku E et al. Regional variation in The incidence of dialysis-requiring AKI in The United States. Clin J Am Soc Nephrol 2013; 8: 1476-1481.
128. Siew ED, Ikizler TA, Matheny ME et al. Estimating baseline kidney function in hospitalized patients with impaired kidney function. Clin J Am Soc Nephrol 2012; 7: 712-719.
129. Siew ED, Peterson JF, Eden SK et al. Use of multiple imputation method to improve estimation of missing baseline serum creatinine in acute kidney injury research. Clin J Am Soc Nephrol 2013; 8: 10-18.
130. Thakar CV, Christianson A, Freyberg R et al. Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study. Crit Care Med 2009; 37: 2552-2558.
131. Joannidis M, Metnitz B, Bauer P et al. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using The SAPS 3 database. Intensive Care Med 2009; 35: 1692-1702.
132. Alpert JS, Thygesen K. A call for universal definitions in cardiovascular disease. Circulation 2006; 114: 757-758.
133. Thygesen K, Alpert JS, Jaffe AS et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012; 60: 1581-1598.
134. Chertow GM, Levy EM, Hammermeister KE et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998; 104: 343-348.
135. Mangano CM, Diamondstone LS, Ramsay JG et al. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998; 128: 194-203.
136. Hobson CE, Yavas S, Segal MS et al. Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation 2009; 119: 2444-2453.
137. Dasta JF, Kane-Gill SL, Durtschi AJ et al. Costs and outcomes of acute kidney injury (AKI) following cardiac surgery. Nephrol Dial Transplant 2008; 23: 1970-1974.
138. Kuitunen A, Vento A, Suojaranta-Ylinen R et al. Acute renal failure after cardiac surgery: evaluation of The RIFLE classification. Ann Thorac Surg 2006; 81: 542-546.
139. Liangos O, Wald R, O'Bell JW et al. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol 2006; 1: 43-51.
140. Uchino S, Bellomo R, Goldsmith D et al. An assessment of The RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med 2006; 34: 1913-1917.
141. Ali T, Khan I, Simpson W et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 2007; 18: 1292-1298.
142. Porter CJ, Juurlink I, Bisset LH et al. A real-time electronic alert to improve detection of acute kidney injury in a large teaching hospital. Nephrol Dial Transplant (advance online publication 16 April 2014; e-pub ahead of print).
143. Brivet FG, Kleinknecht DJ, Loirat P et al. Acute renal failure in intensive care units-causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure. Crit Care Med 1996; 24: 192-198.
144. Hoste EA, Clermont G, Kersten A et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006; 10: R73.
145. Ostermann M, Chang RW. Acute kidney injury in The intensive care unit according to RIFLE. Crit Care Med 2007; 35: 1837-1843.
146. Bagshaw SM, George C, Dinu I et al. A multi-centre evaluation of The RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008; 23: 1203-1210.
147. Bagshaw SM, George C, Bellomo R. A comparison of The RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008; 23: 1569-1574.
148. Bagshaw SM, George C, Bellomo R et al. Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care 2008; 12: R47.
149. Cruz DN, Bolgan I, Perazella MA et al. North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): targeting The problem with The RIFLE Criteria. Clin J Am Soc Nephrol 2007; 2: 418-425.
150. Nisula S, Kaukonen KM, Vaara ST et al. Incidence, risk factors and 90-day mortality of patients with acute kidney injury in Finnish intensive care units: The FINNAKI study. Intensive Care Med 2013; 39: 420-428.
151. Feest TG, Round A, Hamad S. Incidence of severe acute renal failure in adults: results of a community based study. BMJ 1993; 306: 481-483.
152. Khan IH, Catto GR, Edward N et al. Acute renal failure: factors influencing nephrology referral and outcome. QJM 1997; 90: 781-785.
153. Liano F, Pascual J. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid Acute Renal Failure Study Group. Kidney Int 1996; 50: 811-818.
154. Korkeila M, Ruokonen E, Takala J. Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care. Intensive Care Med 2000; 26: 1824-1831.
155. Stevens PE, Tamimi NA, Al-Hasani MK et al. Non-specialist management of acute renal failure. QJM 2001; 94: 533-540.
156. Cole L, Bellomo R, Silvester W et al. A prospective, multicenter study of The epidemiology, management, and outcome of severe acute renal failure in a 'closed' ICU system. Am J Respir Crit Care Med 2000; 162: 191-196.
157. Robertson S, Newbigging K, Isles CG et al. High incidence of renal failure requiring short-term dialysis: a prospective observational study. QJM 2002; 95: 585-590.
158. Prescott GJ, Metcalfe W, Baharani J et al. A prospective national study of acute renal failure treated with RRT: incidence, aetiology and outcomes. Nephrol Dial Transplant 2007; 22: 2513-2519.
159. Parsons DF, Darden EB Jr. Optimal conditions for methacrylate embedding of certain tissues and cells sensitive to polymerization damage. Exp Cell Res 1961; 24: 466-483.
160. Fischer RP, Griffen WO Jr, Reiser M et al. Early dialysis in The treatment of acute renal failure. Surg Gynecol Obstet 1966; 123: 1019-1023.
161. Kleinknecht D, Jungers P, Chanard J et al. Uremic and non-uremic complications in acute renal failure: evaluation of early and frequent dialysis on prognosis. Kidney Int 1972; 1: 190-196.
162. Gettings LG, Reynolds HN, Scalea T. Outcome in post-traumatic acute renal failure when continuous renal replacement therapy is applied early vs. late. Intensive Care Med 1999; 25: 805-813.
163. Mehta RL, McDonald B, Gabbai FB et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001; 60: 1154-1163.
164. Schiffl H, Lang SM, Fischer R. Daily hemodialysis and The outcome of acute renal failure. N Engl J Med 2002; 346: 305-310.
165. Ronco C, Bellomo R, Homel P et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000; 356: 26-30.
166. Bouman CS, Oudemans-Van Straaten HM, Tijssen JG et al. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Critical Care Med 2002; 30: 2205-2211.
167. Cho KC, Himmelfarb J, Paganini E et al. Survival by dialysis modality in critically ill patients with acute kidney injury. J Am Soc Nephrol 2006; 17: 3132-3138.
168. Vinsonneau C, Camus C, Combes A et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 2006; 368: 379-385.
169. Uchino S, Bellomo R, Morimatsu H et al. Continuous renal replacement therapy: a worldwide practice survey: The Beginning and Ending Supportive Therapy for The Kidney (B.E.S.T. Kidney) Investigators. Intensive Care Med 2007; 33: 1563-1570.
170. Carl DE, Grossman C, Behnke M et al. Effect of timing of dialysis on mortality in critically ill, septic patients with acute renal failure. Hemodial Int 2010; 14: 11-17.
171. Prescott GJ, Metcalfe W, Baharani J et al. A prospective national study of acute renal failure treated with RRT: incidence, aetiology and outcomes. Nephrol Dial Transplant 2007; 22: 2513-2519.
172. Palevsky PM, Zhang JH, O'Connor TZ et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008; 359: 7-20.
173. Bellomo R, Cass A, Cole L et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009; 361: 1627-1638.
174. Leonard CE, Freeman CP, Newcomb CW et al. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and The risk of acute interstitial nephritis and acute kidney injury. Pharmacoepidemiol Drug Saf 2012; 21: 1155-1172.
175. Dormuth CR, Hemmelgarn BR, Paterson JM et al. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases. BMJ 2013; 346: f880.
176. Bird ST, Etminan M, Brophy JM et al. Risk of acute kidney injury associated with The use of fluoroquinolones. CMAJ 2013; 185: E475-E482.
177. Hurst FP, Bohen EM, Osgard EM et al. Association of oral sodium phosphate purgative use with acute kidney injury. J Am Soc Nephrol 2007; 18: 3192-3198.
178. Zhao YY, Weir MA, Manno M et al. New fibrate use and acute renal outcomes in elderly adults: a population-based study. Ann Intern Med 2012; 156: 560-569.
179. Schneider V, Levesque LE, Zhang B et al. Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: a population-based, nested case-control analysis. Am J Epidemiol 2006; 164: 881-889.
180. Wikman P, Safont P, Del Palacio M et al. The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients. Nephrol Dial Transplant 2013; 28: 2073-2081.
181. Gandhi S, Fleet JL, Bailey DG et al. Calcium-channel blocker-clarithromycin drug interactions and acute kidney injury. JAMA 2013; 310: 2544-2553.